ArticleMolecular cancer therapeutics2017
Retraction: Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.